Euronews is no longer accessible on Internet Explorer. This browser is not updated by Microsoft and does not support the last technical evolutions. We encourage you to use another browser, such as Edge, Safari, Google Chrome or Mozilla Firefox.

BREAKING NEWS

BREAKING NEWS

GSK's shingles vaccine approved for use in China in adults aged 50 and above

GSK's shingles vaccine approved for use in China in adults aged 50 and above
An exterior view of GlaxoSmithKline (GSK) Asia House is seen in Singapore, March 21, 2018. Picture taken March 21, 2018. REUTERS/Loriene Perera -
Copyright
Loriene Perera(Reuters)
Text size Aa Aa

(Reuters) - GlaxoSmithKline Plc said on Thursday its shingles vaccine had been approved for use in China in adults aged 50 and above.

Shingrix, which has already been approved for use in the European Union, the United States, Canada, Japan and Australia, brought in 357 million pounds in the latest quarter.

The company said the vaccine will be introduced in phases, starting in 2020 to ensure reliable supply to all countries, where it has been launched.

(Reporting by Samantha Machado in Bengaluru; Editing by Anil D'Silva)

euronews provides breaking news articles from reuters as a service to its readers, but does not edit the articles it publishes. Articles appear on euronews.com for a limited time.